The head of the U.N. AIDS agency says the sudden loss of American money has been “devastating” for efforts to stop HIV and ...

The UNAIDS director also warned that US funding cuts could be dire for global efforts to curb HIV. View on euronews ...

US funding cuts will lead to an additional 2,000 new HIV infections each day and over six million further deaths over the ...

Gilead released data showing that an HIV drug, called lenacapavir, could provide virtually complete protection against ...

Promising results from an early-stage trial suggest that lenacapavir injections might offer long-lasting protection.

After Gilead Sciences' lenacapavir made waves with stellar clinical results as a twice-yearly HIV prevention candidate, the ...

Gilead has reported results for a once-yearly intramuscular injection that show blood concentrations of lenacapavir exceeded ...

A single shot of a new formulation of the antiretroviral drug lenacapavir could potentially provide protection against HIV ...

A team of pharmaceutical researchers at biopharma company Gilead Sciences has announced that a reformulation of its HIV ...

New data suggest that lenacapavir delivered just once per year could be as effective for HIV prevention as the twice-yearly ...

The world risks returning to the worst days of the global AIDS pandemic following the sudden halt to US foreign aid funding, ...

Winnie Byanyima, head of UNAIDS, criticized the impact of reduced U.S. funding in combatting HIV. She proposed a deal to U.S.